Business
Jaguar Health Launches FDA-Approved Oral Mucositis Prescription Product Gelclair in the U.S.
Gelclair® is the company's third commercialized prescription productOral mucositis, also called "chemo mouth," a painful inflammation of the mouth's mucous
About this update from Jaguar Health, Inc.
[{"type":"text","content":"Gelclair® is the company's third commercialized prescription productOral mucositis, also called \"chemo mouth,\" a painful inflammation of the mouth's mucous membranes, has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task forceSevere mucositis/pharyngitis occurred in 70% of head and neck cancer patients in third-party study SAN FRANCISCO, CA / ACCESSWIRE / October 16, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (\"Jaguar\") today announced that Jaguar family company Napo Pharmaceuticals (\"Napo\") has initiated the commercial launch of the FDA-approved oral mucositis prescription product Gelclair in the U.S.\"Cancer is chaotic, because patients feel a loss of control - over their life, their treatment, and their supportive care needs,\" said Catherine Collis, Jaguar's Senior Vice President of Growth Strategy. \"Jaguar's mission is to change patients' lives for the better, especially in the area of supportive care for complex disease states like cancer. We are thrilled to have begun our commercial launch of Gelclair. Oral mucositis is undertreated and underappreciated. We believe we can help cancer patients by giving them a supportive care product for oral mucositis that provides soothing, quick, and lasting pain relief without stinging, drying or burning.\"\"We are very happy to have initiated the commercial launch for Gelclair - our third commercialized prescription product. This important milestone initiates Jaguar's commercial footprint in our core focus area of cancer supportive care,\" said Lisa Conte, Jaguar's president and CEO. \"Oral mucositis is among the most common, painful, and debilitating cancer treatment-related side effects. Gelclair is a gel with a mechanical action indicated for the management of pain and relief of pain by adhering to the mucosal surface of the mouth. It coats and protects the oral mucosa, which supports healing. Gelclair is convenient and easy to use, provides rapid and long-lasting pain relief, and improves the ability of oral mucositis patients to eat, drink, and swallow. Unlike other products for oral mucositis, it is not a numbing agent and does not sting the mouth.\"\"A key attribute in the management of head and neck cancer patients with Gelclair is, in my experience, to delay the onset which may decrease the severity of ora...